- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/03 - Halogenated hydrocarbons carbocyclic aromatic
Patent holdings for IPC class A61K 31/03
Total number of patents in this class: 292
10-year publication summary
15
|
18
|
26
|
21
|
29
|
19
|
28
|
41
|
34
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Corcept Therapeutics, Inc. | 318 |
8 |
The Johns Hopkins University | 5524 |
6 |
Bio-Pharm Solutions Co., Ltd. | 60 |
6 |
The Regents of the University of Michigan | 4570 |
5 |
ChemoCentryx, Inc. | 394 |
5 |
The Regents of the University of California | 19493 |
4 |
Orion Corporation | 591 |
4 |
Lunella Biotech, Inc. | 97 |
4 |
GABA Therapeutics Inc. | 6 |
4 |
Ben-Gurion University of the Negev Research and Development Authority | 214 |
3 |
BioMendics, LLC | 12 |
3 |
Gilead Sciences, Inc. | 1951 |
3 |
Regents of the University of Minnesota | 2674 |
3 |
Research Institute at Nationwide Children's Hospital | 531 |
3 |
SK Biopharmaceuticals Co., Ltd. | 257 |
3 |
St. Jude Children's Research Hospital | 240 |
3 |
Merck Sharp & Dohme LLC | 3744 |
3 |
Iolyx Therapeutics, Inc. | 21 |
3 |
Janssen Pharmaceuticals, Inc. | 411 |
2 |
The General Hospital Corporation | 4642 |
2 |
Other owners | 215 |